HomePublicationsCongress AbstractsAbstracts 2011Poster presentations: Epidemiology (2011)

* = Presenting author

Poster presentations: Epidemiology (2011)

P317. Cost-effectiveness of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease (CD)

P318. Mapping of Crohn's disease in Northern France: Spatial and temporal variations of incidence between 1990 and 2006

P319. Dose variations with adalimumab and infliximab in the treatment of Crohn's disease: A Canadian assessment

P320. Prevalence of inflammatory bowel disease is high in Finland

P321. Paediatric IBD – How reliably does the Montreal classification perform?

P322. Dietary oleic acid protects against the development of ulcerative colitis – A UK prospective cohort study using data from food diaries

P323. The traveling IBD patient – A case-controlled study of travel-associated health risks

P324. Influence of dietary habits in susceptibility for inflammatory bowel disease: A case control study

P325. Low sun exposure is associated with an increased risk of Crohn's disease in the E3N cohort study

P326. Decreasing rates of hospital admissions for inflammatory bowel disease between 2000 and 2009

P327. Mortality from inflammatory bowel disease in a healthcare area of Gijon, Spain: Results from the study of a hospital registry from 1992 to 2006

P328. Revaluation of risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: A South-Italian, case–control, multi-centre prospective study

P329. Large scale genomic instability in patients with colorectal cancer in inflammatory bowel disease – Association with clinico­histological factors and survival

P330. Epidemiology of pediatric chronic inflammatory bowel disease in Serbia, 2005–2009

P331. Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis in The Netherlands

P332. Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European collaborative follow-up study

P333. Endotoxin levels and juvenile inflammatory bowel disease – A case–control study

P334. The safety of immunomodulators and anti-TNF drugs for the treatment of inflammatory bowel disease (IBD) during pregnancy

P335. How is the coping in patients with inflammatory bowel disease?

P336. Experimental inflammatory bowel disease registry: Incidence and prevalence in Forli' district in Italy (1993–2009)

P337. Incidental diagnosis of inflammatory bowel disease during bowel cancer screening programme in Northeast Italy

P338. Impact of inflammatory bowel disease on sexual function

P339. Epidemiological study of inflammatory bowel disease in single tertiary centre – First report from Serbia

P340. Differences in demographic data and disease extension in patients with ulcerative colitis associated with primary sclerosing cholangitis

P341. Association of hygienic factors and inflammatory bowel disease in Rio de Janeiro, Brazil

P342. Characteristics of inflammatory bowel disease (IBD) in a cohort of patients of Gypsy ethnicity

P343. Role of plasminogen activator inhibitor and thrombin activatable fibrinolysis inhibitor in the elevated thromboembolic risk seen in inflammatory bowel disease patients

P344. Common misconceptions in the management of outpatients with inflammatory bowel disease (IBD)

P345. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease

P346. Profile of Belgian pediatric Crohn's disease patients: Presentation and diagnostic features

P347. Epidemiological study of perianal fistulas in patients with Crohn's disease

P349. Profile of Belgian pediatric Crohn's disease (CD) patients: Associations between variables at diagnosis

P350. Incidence of inflammatory bowel disease in Kaunas region, Lithuania: A prospective three year study

P351. Gender impact on the clinical presentation of the newly diagnosed, pediatric-onset Crohn's disease: A single center registry-based study

P352. Rates of hospitalization for inflammatory bowel diseases in Poland

P353. Influence of frozen food consumption in risk for developing inflammatory bowel disease

P354. The short health scale is a quick and reliable measure of health status in English speaking patients with Crohn's disease

P355. Prevalence of new serological markers in an old Irish IBD cohort

P356. Irish IBD patients' perception of colorectal cancer screening: Lessons learnt from an 18 years follow up study

P357. Clinical epidemiology of inflammatory bowel disease in a Libyan population

P358. Environmental factors in infancy and ulcerative colitis in Chile: A case–control study

P359. Role of the CYLD protease gene in Crohn's disease, independent from its neighbouring gene CARD15